ShockWave Medical, Inc. (SWAV): Price and Financial Metrics

ShockWave Medical, Inc. (SWAV)

Today's Latest Price: $69.88 USD

0.35 (-0.50%)

Updated Oct 29 4:00pm

Add SWAV to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

SWAV Stock Summary

  • With a one year PEG ratio of 0.21, Shockwave Medical Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 4.51% of US stocks.
  • Shockwave Medical Inc's stock had its IPO on March 7, 2019, making it an older stock than merely 2.75% of US equities in our set.
  • With a price/sales ratio of 46.71, Shockwave Medical Inc has a higher such ratio than 95.55% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Shockwave Medical Inc, a group of peers worth examining would be RAVN, GEOS, KN, CYRN, and VUZI.
  • Visit SWAV's SEC page to see the company's official filings. To visit the company's web site, go to

SWAV Stock Price Chart Interactive Chart >

Price chart for SWAV

SWAV Price/Volume Stats

Current price $69.88 52-week high $79.74
Prev. close $70.23 52-week low $22.01
Day low $69.01 Volume 376,800
Day high $71.46 Avg. volume 451,836
50-day MA $69.86 Dividend yield N/A
200-day MA $49.08 Market Cap 2.38B

ShockWave Medical, Inc. (SWAV) Company Bio

Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.

SWAV Latest News Stream

Event/Time News Detail
Loading, please wait...

SWAV Latest Social Stream

Loading social stream, please wait...

View Full SWAV Social Stream

Latest SWAV News From Around the Web

Below are the latest news stories about Shockwave Medical Inc that investors may wish to consider to help them evaluate SWAV as an investment opportunity.

ShockWave Medical (SWAV) Investor Presentation - Slideshow

The following slide deck was published by ShockWave Medical, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | August 16, 2020

Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11 to 13, 2020. Shockwave's management is scheduled for a live fireside chat on Wednesday, August 12, 2020, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at Shockwave Medical, Inc. Shockwave Medical is focused on developing and commercializing products intended to transform the way calcifi...

Yahoo | July 30, 2020

Shockwave Medical to Report Second Quarter 2020 Financial Results on August 11, 2020

SANTA CLARA, Calif., July 21, 2020 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.

Yahoo | July 21, 2020

Shockwave Appoints Maria Sainz to Board of Directors

SANTA CLARA, Calif., July 20, 2020 -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified.

Yahoo | July 20, 2020

Shockwave Medical Stock Falls After Two Patents Ruled Invalid

Shares of cardiovascular-health company Shockwave Medical (NASDAQ: SWAV) fell on Thursday after the Patent Trial and Appeal Board ruled that two of its patents are invalid. Previously, fellow healthcare-company Cardiovascular Systems (NASDAQ: CSII) challenged two of Shockwave Medical's patents and asked the U.S. Patent and Trademark Office to look into it. The '371 patent adds a couple of electrodes inside a balloon catheter to help break up calcification in blood vessels.

Yahoo | July 9, 2020

Read More 'SWAV' Stories Here

SWAV Price Returns

1-mo -7.81%
3-mo 41.69%
6-mo 82.03%
1-year 105.41%
3-year N/A
5-year N/A
YTD 59.11%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7509 seconds.